Quality Care
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
The companies will create a value-based care program to support cardiology patients and providers at health systems and CINs.
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
It has also received Australia's regulatory approval for its AI solution.
The company will use the investment to expand its reach across the U.S. and develop new technologies.
mCareWatch 241 aims to allow individuals who may need emergency assistance, like those with disabilities or senior citizens, to access the help they need quickly.
Also, Kakao Healthcare is extending access to its AI to a public diabetes screening programme in South Korea.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.